BiolineRx
Jerusalem
About BiolineRx
BioLineRx is a clinical-stage, publicly traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $286.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2025)
- Ticker: tlv:BLRX
- Website: biolinerx.com
- Phone: +972 2-548-9100
Industries & Categories
Biotechnology, Medical Device, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/biolinerx-126470 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.